Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer. Discover why early detection makes treatment more effective and far less ...
A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...
A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...
Nurses and advanced practice registered nurses (APRNs) play a central role in preventive care, screening, chronic disease management, and patient education. Expanding this workforce is particularly ...
FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.
Study finds similar safety regardless of anticoagulant type.In a study of adults with advanced prostate cancer taking androgen-receptor pathway ...
A drug for advanced prostate cancer has shown “remarkable” results in an early-stage trial, experts have said. The treatment ...
There are different ways to manage fatigue during prostate cancer treatment, including exercise, sleep, complementary ...
CCT400028 has been recognised as a high-quality chemical probe and is recommended by the Chemical Probes Portal as a leading Aurora A degrader for laboratory use. The molecule provides researchers ...
A “search and destroy” treatment has been found to halt tumours in some men with incurable prostate cancer. The early-stage ...
Click here for a copy of the latest data. New data has revealed a 25% increase in the number of deaths from prostate cancer in Australia since 2007 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results